Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Mucke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|December 24, 2003
Sixth COngress of the European Federation of Neurological SocietiesHermann Mucke
Assay and Drug Development Technologies|December 14, 2017
Old Compounds, New Uses, New Ways: Many WaysHermann Mucke
Expert Opinion on Investigational Drugs|November 30, 2002
Therapies in development for the treatment of migraineHermann Mucke
Assay and Drug Development Technologies|December 23, 2015
Interview with Raúl Insa, MD, PhDRaúl Insa, Hermann Mucke
Wiener Klinische Wochenschrift|January 8, 2013
Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian settingMichael Rainer, Hermann Mucke, Sandra Schlaefke
Handbook of Experimental Pharmacology|August 12, 2020
NOX Inhibitors: From Bench to Naxibs to BedsideMahmoud H Elbatreek, Hermann Mucke, Harald H H W Schmidt
Cardiovascular Research|July 16, 2021
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacologyAlexandra Petraina, Cristian Nogales, Thomas Krahn, et al.
JACC. Advances|February 22, 2025
Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study)Daniel Sedding, Tim M Schmidt, Heike Bähre, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|December 24, 2003
Sixth COngress of the European Federation of Neurological SocietiesHermann Mucke
Assay and Drug Development Technologies|December 14, 2017
Old Compounds, New Uses, New Ways: Many WaysHermann Mucke
Expert Opinion on Investigational Drugs|November 30, 2002
Therapies in development for the treatment of migraineHermann Mucke
Assay and Drug Development Technologies|December 23, 2015
Interview with Raúl Insa, MD, PhDRaúl Insa, Hermann Mucke
Wiener Klinische Wochenschrift|January 8, 2013
Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian settingMichael Rainer, Hermann Mucke, Sandra Schlaefke
Handbook of Experimental Pharmacology|August 12, 2020
NOX Inhibitors: From Bench to Naxibs to BedsideMahmoud H Elbatreek, Hermann Mucke, Harald H H W Schmidt
Cardiovascular Research|July 16, 2021
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacologyAlexandra Petraina, Cristian Nogales, Thomas Krahn, et al.
JACC. Advances|February 22, 2025
Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study)Daniel Sedding, Tim M Schmidt, Heike Bähre, et al.
Pageof 1